- Home
- WMK vs TARS Comparison
WMK vs TARS Comparison
Compare WMK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- TARS
- Stock Information
- Founded
- WMK 1912
- TARS 2016
- Country
- WMK United States
- TARS United States
- Employees
- WMK N/A
- TARS N/A
- Industry
- WMK Food Chains
- TARS Medicinal Chemicals and Botanical Products
- Sector
- WMK Consumer Staples
- TARS Health Care
- Exchange
- WMK Nasdaq
- TARS Nasdaq
- Market Cap
- WMK 1.8B
- TARS 1.7B
- IPO Year
- WMK N/A
- TARS 2020
- Fundamental
- Price
- WMK $70.83
- TARS $49.36
- Analyst Decision
- WMK
- TARS Strong Buy
- Analyst Count
- WMK 0
- TARS 7
- Target Price
- WMK N/A
- TARS $67.14
- AVG Volume (30 Days)
- WMK 124.0K
- TARS 652.0K
- Earning Date
- WMK 11-04-2025
- TARS 11-12-2025
- Dividend Yield
- WMK 1.91%
- TARS N/A
- EPS Growth
- WMK 15.99
- TARS N/A
- EPS
- WMK 4.02
- TARS N/A
- Revenue
- WMK $4,842,632,000.00
- TARS $295,521,000.00
- Revenue This Year
- WMK N/A
- TARS $33,170.29
- Revenue Next Year
- WMK N/A
- TARS N/A
- P/E Ratio
- WMK $17.76
- TARS N/A
- Revenue Growth
- WMK 1.75
- TARS 254.45
- 52 Week Low
- WMK $62.25
- TARS $30.23
- 52 Week High
- WMK $90.23
- TARS $59.76
- Technical
- Relative Strength Index (RSI)
- WMK 44.01
- TARS 36.86
- Support Level
- WMK $68.55
- TARS $55.45
- Resistance Level
- WMK $71.56
- TARS $59.76
- Average True Range (ATR)
- WMK 1.70
- TARS 2.01
- MACD
- WMK -0.11
- TARS -1.34
- Stochastic Oscillator
- WMK 40.21
- TARS 8.77
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.